Cochlear Limited
COH
Rang in aandelen
#2853
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Aandeelprijs
$99.82
Marktkapitalisatie
$6.53B
Verandering (1 dag)
1.03%
Verandering (1 jaar)
-46.67%
Land
AU
Handel Cochlear Limited (COH)
Categorie
Healthcare
P/B-ratio voor Cochlear Limited (COH)
P/B-ratio op October 2026 TTM: 4.84
Volgens de meest recente financiële rapporten en aandelenkoers van Cochlear Limited is de huidige P/B-ratio (TTM) 4.84. Eind 2024 had het bedrijf een P/B-ratio van 11.49.
P/B-ratiohistoriek voor Cochlear Limited van 2000 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 4.84 | -52.02% |
| 2025 | 10.08 | -12.24% |
| 2024 | 11.49 | 33.32% |
| 2023 | 8.62 | 11.19% |
| 2022 | 7.75 | -20.87% |
| 2021 | 9.79 | 25.90% |
| 2020 | 7.78 | -53.24% |
| 2019 | 16.63 | -11.58% |
| 2018 | 18.81 | 15.09% |
| 2017 | 16.34 | 6.15% |
| 2016 | 15.39 | 19.90% |
| 2015 | 12.84 | 20.42% |
| 2014 | 10.66 | 9.55% |
| 2013 | 9.73 | 0.12% |
| 2012 | 9.72 | 20.06% |
| 2011 | 8.10 | -15.15% |
| 2010 | 9.54 | 7.86% |
| 2009 | 8.85 | 16.89% |
| 2008 | 7.57 | -40.89% |
| 2007 | 12.80 | -10.80% |
| 2006 | 14.35 | 8.74% |
| 2005 | 13.20 | 49.79% |
| 2004 | 8.81 | -37.84% |
| 2003 | 14.18 | -40.31% |
| 2002 | 23.75 | -34.73% |
| 2001 | 36.39 | 6.31% |
| 2000 | 34.23 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 3.5116 | -27.40% |
US
|
|
| 2.0146 | -58.35% |
IE
|
|
| 4.5025 | -6.91% |
US
|
|
| 2.5486 | -47.31% |
US
|
|
| - | - |
DE
|
